MLchartDataset catalogue

ATR-101

Term · Oncology and biomedicine · MLC-T-ONC-011287

An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101 selectively kills adrenal and adrenal cancer cells, through an unknown mechanism.

Table 1. Record
IdentifierMLC-T-ONC-011287
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-011287",
  "term": "ATR-101",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101 selectively kills adrenal and adrenal cancer cells, through an unknown mechanism.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/atr-101/"
}

Record 2,569 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.